GLP-2 TZ
GLP-2 TZ is a long-acting dual agonist peptide targeting GLP-1 and GIP receptors. Preclinical research explores its potent effects on weight management, glycemic control, and metabolic regulation.
Key Research Areas
- • Studied for dual agonism at GLP-1R and GIPR for synergistic metabolic and weight loss effects.
- • Investigated for substantial body weight reduction through appetite suppression and improved energy balance.
- • Explored for enhancements in glycemic control, insulin secretion, and lipid metabolism in obesity and diabetes models.
Product Specifications
| Product |
GLP-2 TZ |
| CAS Number |
2023788-19-2 |
| Molecular Formula |
C225H348N48O68 |
| Molar Mass |
4813.45 g/mol |
| Sequence |
Modified lipidated 39-amino acid dual agonist peptide |
| Synonyms |
GLP-2 TZ; Tirz; LY3298176; dual GIP/GLP-1 agonist |
| Purity |
≥99% (HPLC) |
| Form |
Lyophilized powder |
| Storage |
−20°C (−4°F) long-term; 2–8°C (36–46°F) reconstituted |
| Solubility |
Bacteriostatic water for laboratory use |
All products offered by Premier Research are intended for laboratory research use only. These materials are not for human or veterinary consumption, medical use, diagnostic procedures, or therapeutic applications. Statements on this website are for informational and educational purposes only and have not been evaluated by the U.S. Food and Drug Administration (FDA). By accessing this site, you confirm that you are a qualified researcher or institution representative and agree to use all materials in accordance with applicable laws, regulations, and safety guidelines.
